Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path for Blood Disorder Diagnosis, complementing bone marrow procedures PLEASANTON, Calif. and REHOVOT, Israel — CLISEQ Ltd., a translational diagnostics company spun out of Yeda, the commercial arm of the Weizmann Institute of Science, today announced a translational research […]
Aspect Analytics raises €10 million Series A to expand global leadership in spatial biology software
Genk (BE) — Aspect Analytics, a leading provider of software for spatial biology data analysis, announced the successful closing of an oversubscribed € 10 million Series A funding round. The investment will accelerate the company’s international expansion, support continued innovation, and reinforce its position as the leader in spatial multi-omic data integration and large-scale research […]
WALTHAM, MASS. – Biopharma and clinical researchers can face challenges in optimizing qPCR multiplexing workflows, which are essential for reducing costs, conserving target samples, minimizing consumables, and increasing throughput in genetic analysis studies. To streamline the multiplexing workflow, Thermo Fisher Scientific has launched the new MGB probes for up to 5-plex multiplexing, paired with a modernized […]
Abselion Launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes Kits incorporate Thermo Fisher Scientific’s CaptureSelect affinity reagents for enhanced specificity and consistency Cambridge, UK: Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its product offering, […]
Green level certification represents the pinnacle of lab sustainability SANTA CLARA, California — Agilent Technologies Inc. (NYSE: A) today announced that its Refurbishment Centers in Delaware, USA, and Singapore have achieved the highest level of My Green Lab Certification—Green level— an internationally recognized benchmark for laboratory sustainability. This milestone underscores Agilent’s commitment to environmental stewardship and innovation in sustainable lab operations. The certification process […]
Avidion brings clarity to immune drug-tumor interactions, helping scientists identify better cell therapy candidates, understand mechanisms, and advance with confidence. Amsterdam, Netherlands – LUMICKS announces the European launch of Avidion, the next generation Cell Avidity platform, at the upcoming CICON 2025 conference on September 10-12 in Utrecht, The Netherlands. 83% of CAR-T cell therapies fail after preclinical development [1], […]
Partnership delivers advanced reverse transcriptase technology to enhance sensitivity, robustness and reproducibility of molecular analysis in clinical, applied and pharmaceutical applications Madison, WI and Boulder, CO, USA. — Promega has entered a strategic partnership with Watchmaker Genomics to license a novel engineered reverse transcriptase. Designed for enhanced accuracy and sensitivity in RNA analysis, the enzyme will enhance Promega […]
Veteran life sciences industry financing leader appointed as new Board member HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced the appointment of Stephen DeNelsky to its Board of Directors, effective September 5, 2025. Mr. DeNelsky will also serve on the Board’s Nominating and Governance Committee. “We are pleased […]
ST. PAUL, Minn. — ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that eight (8) G-Rex Grants, totaling nearly $2 million in support, have been awarded to awardees of the California Institute for Regenerative Medicine (CIRM) Manufacturing Network (INFR5) program. CIRM has developed a unique funding opportunity for non-profit […]
Elegen’s cell-free gene synthesis platform delivers full-length, high-complexity linear DNA with encoded poly(A) tails up to three times faster and free from bioburden, endotoxins and recombination-mediated variation. MENLO PARK, Calif. — #CGT—Elegen, a global leader in next-generation cell-free DNA manufacturing, today announced the full commercial launch of ENFINIA™ IVT Ready DNA — engineered for immediate use in in vitro transcription […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
